Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21330 |
JNJ-28312141
JNJ 28312141,JNJ28312141 |
||
JNJ-28312141 is an orally active CSF1R inhibitor and a FLT3 inhibitor. JNJ-28312141 is a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSF-1-dependent macrophages and osteoclasts contribute to tumor growth a |